
Moderna Inc. said the U.S. government exercised its option to buy 100 million additional doses of the company’s coronavirus vaccine candidate, doubling the amount of the shot it initially committed to purchase and easing concern that the U.S. could be left with a vaccine shortfall.
More Stories
How to land a good work-from-home job
Pfizer’s COVID-19 vaccine has begun rolling out of its Michigan plant in a truck convoy
Iran Sets Out Ambitions to Hike Oil Production Next Year